Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 16775229.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors conducted a double-blind, placebo-controlled, crossover study to investigate the efficacy of oral zolmitriptan in the treatment of migraine in children and adolescents. Patients (n = 32) received placebo, zolmitriptan 2.5 mg, and ibuprofen 200 to 400 mg to treat three consecutive migraine attacks. Pain relief rates after 2 hours were 28% for placebo, 62% for zolmitriptan, and 69% for ibuprofen (p < 0.05). Both drugs are well tolerated with only mild side effects.
Medical subject headings
- Ibuprofen
- Migraine Disorders
- Oxazolidinones
- Tryptamines